March 18, 2020 / 10:23 PM / 10 days ago

BRIEF-Capricor Therapeutics Q4 Loss Per Share $0.34

March 18 (Reuters) - Capricor Therapeutics Inc:

* CAPRICOR THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 LOSS PER SHARE $0.34

* EXOSOMES PLATFORM TECHNOLOGY EXPANDED TO POTENTIALLY COMBAT NOVEL CORONAVIRUS

* EXPECTS CASH RESOURCES AT DEC. 31 WILL BE SUFFICIENT TO COVER EXPENSES THROUGH AT LEAST Q2 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below